Learn more about whether Inari Medical, Inc. or DENTSPLY SIRONA Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Bausch + Lomb Corporation or Inari Medical, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Inari Medical Inc (NARI) stock saw a modest uptick, ending the day at $79.74 which represents a slight increase of $0.28 or 0.35% from the prior close of $79.46. The stock opened at $79.54 and touched ...

Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today its ...

Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2024: Fourth Quarter Results Full Year Results “We delivered another year of double-digit organic sales growth ...

Monteverde & Associates PC (the 'M&A Class Action Firm'), has recovered millions of dollars for shareholders and is ...

Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.7, marking a significant milestone for the ...

Investing.com - Inari Med reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations. Inari Med announced earnings per share ...

KNOWN for its innovative take on the classic Japanese sukiyaki experience, Inari Sukiyaki has officially opened its second store at the 4th level of SM Aura Premier, 26th Street corner McKinley ...

Perched on a wooded hillside in southern Kyoto, Fushimi Inari is a 1,300-year-old temple dedicated to Inari, the Shinto deity of rice and sake (Japanese rice wine). The shrine complex dates back ...